Resveratrol inhibits cyclooxygenase-2 transcription in human mammary epithelial cells

Annals of the New York Academy of Sciences

Volumn 889, Issue , 1999, Pages 214-223

  Subbaramaiah, Kotha ^a,b   Michaluart, Pedro ^c   Chung, Wen Jing ^a   Tanabe, Tadashi ^d   Telang, Nitin ^b   Dannenberg, Andrew J ^a,b  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b Anne Fisher Nutr Ctr Strang C   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; ENZYME INHIBITOR; PHORBOL ESTER; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTEIN C JUN; PROTEIN KINASE C; RESVERATROL; TRANSCRIPTION FACTOR AP 1;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; BREAST EPITHELIUM; CANCER PREVENTION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG STRUCTURE; ENZYME INDUCTION; ENZYME INHIBITION; EPITHELIUM CELL; GENE INDUCTION; HUMAN; HUMAN CELL; MOUTH MUCOSA; PROMOTER REGION; PROSTAGLANDIN SYNTHESIS;

VITACEAE;

EID: 0006365030     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb08737.x     Document Type: Conference Paper

References (29)

1. 1. Funk, C.D., L.B. Funk, M.E. Kennedy, A.S. Pong & G.A. FitzGerald. 1991. Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment. FASEB J. 5: 2304-2312.
2. 2. Subbaramaiah, K., N. Telang, J.T. Ramonetti, R. Araki, B. Devito, B.B. Weksler & A.J. Dannenberg. 1996. Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Res. 56: 4424-4429.
3. 3. DuBois, R.N., J. Award, J. Morrow, L.J. Roberts & P.R. Bishop. 1994. Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-α and phorbol ester. J. Clin. Invest. 93: 493-498.
4. 4. Kelley, D.J., J.R. Mestre, K. Subbaramaiah, P.G. Sacks, S.P. Schantz, T. Tanabe, H. Inoue, J.T. Ramonetti & A.J. Dannenberg. 1997. Benzo[a]pyrene up-regulates cyclooxygenase-2 gene expression in oral epithelial cells. Carcinogenesis 18: 795-799.
5. 5. Kutchera, W., D.A. Jones, N. Matsunami, J. Groden, T.M. McIntyre, G.A. Zimmerman, R.L. White & S.M. Prescott. 1996. Prostaglandin H synthase-2 is expressed abnormally in human colon cancer: Evidence for a transcriptional effect. Proc. Natl. Acad. Sci. USA 93: 4816-4820.
6. 6. Sheng, G.G., J. Shao, H. Sheng, E.B. Hooton, P.C. Isakson, J.D. Morrow, R.J. Coffey, R.N. DuBois & R.D. Beauchamp. 1997. A selective cyclooxygenase-2 inhibitor suppresses the growth of H-ras-transformed rat intestinal epithelial cells. Gastroenterology 113: 1883-1891.
7. 7. Kargman, S.L., G.P. O'Neil., P.J. Vickers, J.F. Evans, J.A. Mancini & J.A. Jothy. 1995. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res. 55: 2556-2559.
8. 8. Parett, M.L., R.E. Harris, F.S. Joarder, M.S. Ross, K.P. Clausen & F.M. Robertson. 1997. Cyclooxygenase-2 gene expression in human breast cancer. Int. J. Oncol. 10: 503-507.
9. 9. Ristimaki, A., N. Honkanen, H. Jankala, P. Sipponen & M. Harkonen. 1997. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res. 57: 1276-1280.
10. 10. Muller-Decker, K., K. Scholz, R. Marks & G. Furstenberger. 1995. Differential expression of prostaglandin H synthase isozymes during multistage carcinogenesis in mouse epidermis. Mol. Carcinogenesis 12: 31-41.
11. Δ716 knockout mice by inhibition of cyclooxygenase 2 (Cox-2). Cell 87: 803-809.
12. 12. Kawamori, T., C.V. Rao, K. Seibert & B.S. Reddy. 1998. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res. 58: 409-412.
13. 13. Mestre, J.R., K. Subbaramaiah, P.G. Sacks, S.P. Schantz, T. Tanabe, H. Inoue & A.J. Dannenberg. 1997. Retinoids suppress phorbol ester-mediated induction of cyclooyxgenase-2. Cancer Res. 57: 1081-1085.
14. 14. Mestre, J.R., K. Subbaramaiah, P.G. Sacks, S.P. Schantz, T. Tanabe, H. Inoue & A.J. Dannenberg. 1997. Retinoids suppress epidermal growth factor-induced transcription of cyclooxygenase-2 in human oral squamous carcinoma cells. Cancer Res. 57: 2890-2895.
15. 15. Subbaramaiah, K., W.J. Chung, P. Michaluart, N. Telang, T. Tanabe, H. Inoue, M. Jang, J.M. Pezzuto & A.J. Dannenberg. 1998. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J. Biol. Chem. 273: 21875-21882.
16. 16. Jang, M., L. Cai, G.O. Udeani, K.V. Slowing, C.F. Thomas, C.W.W. Beecher, H.H.S. Fong, N.R. Farnsworth, A.D. Kinghorn, R.G. Mehta, R.C. Moon & J.M. Pezzuto. 1997. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275: 218-220.
17. 17. Zhai, Y-F., H. Beittenmiller, B. Wang, M.N. Gould, C. Oakley, W.J. Esselman & C.W. Welsch. 1993. Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene. Cancer Res. 53: 2272-2278.
18. 18. Sacks, P.G. 1996. Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head. Cancer Metastasis Rev. 15: 27-51.
19. 19. Inoue, H., C. Yokoyama, S. Hara, Y. Tone & T. Tanabe. 1995. Transcriptional regulation of human prostaglandin-endoperoxide synthase-2 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells. J. Biol. Chem. 270: 24965-24971.
20. 20. Masferrer, J.L., B.S. Zweifel, P.T. Manning, S.D. Hauser, K.M. Leahy, W.G. Smith, P.C. Isakson & K. Seibert. 1994. Selective inhibition of inducible cyclooxygenase-2 in vivo is antiinflammatory and nonulcerogenic. Proc. Natl. Acad. Sci. USA 91: 3228-3232.
21. 21. Subbaramaiah, K., D. Zakim, B.B. Weksler & A.J. Dannenberg. 1997. Inhibition of cyclooxygenase: A novel approach to cancer prevention. Proc. Soc. Exp. Biol. Med. 216: 201-210.
22. 22. Liu, J-Y., S-J. Lin & J-K. Lin. 1993. Inhibitory effects of curcumin on protein kinase C activity induced by 12-O-tetradecanoyl-phorbol-13-acetate in NIH 3T3 cells. Carcinogenesis 14: 857-861.
23. 23. Huang, T-S., S-C. Lee & J-K. Lin. 1991. Suppression of c-Jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells. Proc. Natl. Acad. Sci. USA 88: 5292-5296.
24. 24. Gordge, P.C., M.J. Hulme, R.A. Clegg & W.R. Miller. 1996. Elevation of protein kinase A and protein kinase C activities in malignant as compared with normal human breast tissue. Eur. J. Cancer 32A: 2120-2126.
25. 25. Xie, W. & H.R. Herschman. 1995. v-src induces prostaglandin synthase-2 gene expression by activation of c-Jun N-terminal kinase and the c-Jun transcription factor. J. Biol. Chem. 270: 27622-27628.
26. 26. Yoshioka, K., T. Deng, M. Cavigelli & M. Karin. 1995. Antitumor promotion by phenolic anlioxidants: Inhibition of AP-1 activity through induction of Fra expression. Proc. Natl. Acad. Sci. USA 92: 4972-4976.
27. 27. Suzuki, T., H. Okuno, T. Yoshida, T. Endo, H. Nishina & H. Iba. 1992. Difference in transcriptional regulatory function between c-Fos and Fra-2. Nucleic Acids Res. 19: 5537-5542.
28. 28. Karin, M. 1995. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270: 16483-16486.
29. 29. Pfahl, M. 1993. Nuclear receptor/AP-1 interaction. Endocr. Rev. 14: 651-658.